🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

India's vaccine diplomacy in south Asia pushes back against China

Published 21-01-2021, 02:38 pm

By Sanjeev Miglani and Gopal Sharma

NEW DELHI/KATHMANDU, Jan 21 (Reuters) - India will give millions of doses of COVID-19 vaccine to South Asian countries in the next few weeks, government sources said on Thursday, drawing praise from its neighbours and pushing back against China's dominating presence in the region.

Free shipments of AstraZeneca's vaccine manufactured by the Serum Institute of India, the world's biggest producer of vaccines, have begun arriving in the Maldives, Bhutan, Bangladesh and Nepal.

Myanmar and the Seychelles are next in line to get free consignments as India uses its strength as one of the world's biggest makers of generic drugs to build friendships.

"The government of India has shown goodwill by providing the vaccine in grant. This is at the people's level, it is the public who are suffering the most from COVID-19," said Nepal's Minister for Health and Population Hridayesh Tripathi.

The gesture comes at a time that India's ties with Nepal have been strained by a territorial dispute and Indian concern over China's expanding political and economic influence in the Himalayan nation sandwiched between the Asian giants.

China, which had promised Nepal help to deal with the pandemic, is awaiting Nepali clearance for its Sinopharm shots.

"We've asked them to submit more documents and information before we give them the approval," said Santosh K.C., spokesman for Nepal's department of drug administration.

Bangladesh was supposed to get 110,000 doses of vaccine free from Chinese firm Sinovac Biotech, but Bangladesh refused to contribute towards the development cost of the vaccine leading to deadlock.

Bangladesh has instead turned to India for urgent supplies and on Thursday was due to receive 2 million shots of the AstraZeneca vaccine as a gift from India.

"India is making the AstraZeneca vaccine which makes all the difference. It can be stored and transported at normal refrigerated temperatures and countries like Bangladesh have that facility," a Bangladesh health official said.

India for years has struggled to match the pace of Chinese investment in countries such as Sri Lanka, Nepal and the Maldives, where China is building ports, roads and power stations as part of its Belt and Road Initiative.

But the demand for vaccines in these countries desperate to revive their tourism-dependent economies has offered Prime Minister Narendra Modi's government a way to claw back ground, diplomats say.

India is considering giving away anything from 12 million to 20 million shots to its neighbours in the first wave of assistance over the next three to four weeks, one government source said.

India is also helping with the training of health workers in some of these countries and the setting up of the infrastructure to administer the shots, the source said.

"It's a well-crafted, calibrated series of actions you are seeing, they confirm the validity of our 'neighbourhood first' policy," said a former Indian ambassador, Rajiv Bhatia.

"It plays to our strengths in science and pharma, and this is our moment to shine."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.